24
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

The Impact of Comorbidities and Sociodemographic Predictors on Pneumococcal Vaccination Coverage in Adults with Coronary Heart Disease

ORCID Icon, , , ORCID Icon, & ORCID Icon
Pages 11-19 | Received 12 Jul 2023, Accepted 10 Nov 2023, Published online: 19 Dec 2023

References

  • Musher DM , Rueda AM , Kaka AS , Mapara SM . The association between pneumococcal pneumonia and acute cardiac events. Clin. Infect. Dis. 45(2), 158–165 (2007).
  • Africano HF , Serrano-Mayorga CC , Ramirez-Valbuena PC et al. Major adverse cardiovascular events during invasive pneumococcal disease are serotype dependent. Clin. Infect. Dis. 72(11), e711–e719 (2021).
  • Marques Antunes M , Duarte GS , Brito D et al. Pneumococcal vaccination in adults at very high risk or with established cardiovascular disease: systematic review and meta-analysis. Eur. Heart J. Qual. Care Clin. Outcomes 7(1), 97–106 (2021).
  • Fitzgerald D , Waterer GW . Invasive pneumococcal and meningococcal disease. Infect. Dis. Clin. North Am. 33(4), 1125–1141 (2019).
  • Jaiswal V , Ang SP , Lnu K et al. Effect of pneumococcal vaccine on mortality and cardiovascular outcomes: a systematic review and meta-analysis. J. Clin. Med. 11(13), 10–11 (2022).
  • Zampetakis LA , Melas C . The health belief model predicts vaccination intentions against COVID-19: a survey experiment approach. Appl. Psychol. Health Well Being 13(2), 469–484 (2021).
  • Lee K-C , Han K , Kim JY et al. Socioeconomic status and other related factors of seasonal influenza vaccination in the South Korean adult population based on a nationwide cross-sectional study. PLOS ONE 10(2), e0117305 (2015).
  • Salmon DA , Dudley MZ , Glanz JM , Omer SB . Vaccine hesitancy. Vaccine 33, D66–D71 (2015).
  • Kumar S , Shah Z , Garfield S . Causes of vaccine hesitancy in adults for the influenza and COVID-19 vaccines: a systematic literature review. Vaccines (Basel) 10(9), 1518 (2022).
  • Gatwood J , McKnight M , Frederick K et al. Extent of and reasons for vaccine hesitancy in adults at high-risk for pneumococcal disease. Am. J. Health Prom. 35(7), 908–916 (2021).
  • Boucher VG , Pelaez S , Gemme C , Labbe S , Lavoie KL . Understanding factors associated with vaccine uptake and vaccine hesitancy in patients with rheumatoid arthritis: a scoping literature review. Clin. Rheumatol. 40(2), 477–489 (2021).
  • Ioannou GN , Green P , Locke ER , Berry K . Factors associated with early receipt of COVID-19 vaccination and adherence to second dose in the Veterans Affairs healthcare system. PLOS ONE 16(12), e0259696 (2021).
  • Frank O , de Oliveira Bernardo C , González-Chica DA , Macartney K , Menzies R , Stocks N . Pneumococcal vaccination uptake among patients aged 65 years or over in Australian general practice. Hum. Vaccin. Immunother. 16(4), 965–971 (2020).
  • The Center for Disease Control and Prevention, USA . ‘NHIS - About the National Health Interview Survey’ (2022). www.cdc.gov/nchs/nhis/about_nhis.htm
  • Idris I , Deepa R , Fernando DJ , Mohan V . Relation between age and coronary heart disease (CHD) risk in Asian Indian patients with diabetes: a cross-sectional and prospective cohort study. Diabetes Res. Clin. Pract. 81(2), 243–249 (2008).
  • Diseases NC for I and R . ‘Pneumococcal Vaccination: Who and When to Vaccinate | CDC’ (2022). www.cdc.gov/vaccines/vpd/pneumo/hcp/who-when-to-vaccinate.html
  • The Center for Disease Control and Prevention, USA . ‘Vaccination Coverage among Adults in the United States, National Health Interview Survey, 2019–2020 | CDC’. 9, (2022). www.cdc.gov/vaccines/imz-managers/coverage/adultvaxview/pubs-resources/vaccination-coverage-adults-2019-2020.html
  • Ostropolets A , Shoener Dunham L , Johnson KD , Liu J . Pneumococcal vaccination coverage among adults newly diagnosed with underlying medical conditions and regional variation in the US. Vaccine 40(33), 4856–4863 (2022).
  • Vila-Córcoles A , Ochoa-Gondar O , de Diego C , Satué E , Vila-Rovira A , Aragón M . Pneumococcal vaccination coverages by age, sex and specific underlying risk conditions among middle-aged and older adults in Catalonia, Spain, 2017. Eurosurveillance 24(29), (2019).
  • Nowalk MP , Wateska AR , Lin CJ et al. Racial disparities in adult pneumococcal vaccination indications and pneumococcal hospitalizations in the US. J. Natl Med. Assoc. 111(5), 540–545 (2019).
  • Chowkwanyun M . What Is a “Racial Health Disparity”? Five analytic traditions. J. Health Polit. Policy Law 47(2), 131–158 (2022).
  • Sohn H . Racial and ethnic disparities in health insurance coverage: dynamics of gaining and losing coverage over the life-course. Popul. Res. Policy Rev. 36(2), 181–201 (2017).
  • Bhanu C , Gopal DP , Walters K , Chaudhry UAR . Vaccination uptake amongst older adults from minority ethnic backgrounds: a systematic review. PLOS Med. 18(11), e1003826 (2021).
  • Kesiena O , Atarere J , Singireddy S , Ademiluyi A , Famojuro O . The role of health information technology in pneumococcal vaccination uptake among adults with heart disease. Telemedicine e-Health 28(5), 699–705 (2022).
  • Gilani F , Majumdar SR , Johnson JA , Simpson SH . Factors associated with pneumococcal vaccination in 2040 people with type 2 diabetes: a cross-sectional study. Diabetes Metab. 46(2), 137–143 (2020).
  • Zens KD , Baroutsou V , Fehr JS , Lang P . Pneumococcal vaccination coverage and uptake among adults in switzerland: a nationwide cross-sectional study of vaccination records. Front. Public Health 9, 9 (2022).
  • National Center for Immunization and Respiratory Diseases . ‘Pneumococcal Vaccination: Summary of Who and When to Vaccinate’ (2023). www.cdc.gov/vaccines/vpd/pneumo/hcp/who-when-to-vaccinate.html#adults-19-64
  • Hanada S , Takata M , Morozumi M , Iwata S , Fujishima S , Ubukata K . Multiple comorbidities increase the risk of death from invasive pneumococcal disease under the age of 65 years. J. Infect. Chemother. 27(9), 1311–1318 (2021).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.